The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection

The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection

<p>Abstract</p> <p>Background</p> <p>Nasopharyngeal carcinoma (NPC) is common among Southern Chinese and the main histology is the undifferentiated carcinoma associated with Epstein-Barr virus (EBV) infection. p63 is a recently proved member of the p53 family based on t...

Full description

Bibliographic Details
Main Authors:	Li Da-Jiang, Pan Zhi-Gang, Guo Can, Yun Jing-Ping, Zheng Mei-Zhen, Hu Zhe-Yu, Cheng Li-Zhen, Zeng Yi-Xin
Format:	Article
Language:	English
Published:	BMC 2006-05-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/4/1/23

Similar Items

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
by: Wenting Li, et al.
Published: (2023-01-01)

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
by: Jiang Li, et al.
Published: (2007-11-01)

Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
by: Justin Yu, et al.
Published: (2021-12-01)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
by: Ya Cao
Published: (2017-05-01)

The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
by: Weixing Liu, et al.
Published: (2021-03-01)

EBV-Associated Hub Genes as Potential Biomarkers for Predicting the Prognosis of Nasopharyngeal Carcinoma
by: Tengteng Ding, et al.
Published: (2023-09-01)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
by: Naveed Ahmed, et al.
Published: (2022-12-01)

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2019-10-01)

EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation.
by: Xiaoting Xu, et al.
Published: (2024-01-01)

CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
by: Samantha Wei-Man Lun, et al.
Published: (2012-01-01)

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
by: Hao Peng, et al.
Published: (2021-07-01)

Convetional Biopsy To EBV Amplification Kit In Quick Diagnosis Of Nasopharyngeal Carcinoma.
by: Hassan, Shahid
Published: (2004)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
by: Han Zhou, et al.
Published: (2020-04-01)

Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study
by: Huan Dong, et al.
Published: (2023-07-01)

Systematic comparison of plasma EBV DNA, anti‐EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma
by: Tan, Lu Ping, et al.
Published: (2020)

A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China
by: Qiao He, et al.
Published: (2023-07-01)

The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma
by: Shuzhan Li, et al.
Published: (2024-03-01)

Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma
by: Jiajun Xie, et al.
Published: (2021-09-01)

Correlation Between Immune Function Status and EBV DNA in Patients with Nasopharyngeal Carcinoma and Their Influence on Prognosis
by: WEI Xueling, et al.
Published: (2021-06-01)

EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma
by: Lung, R. W. M., et al.
Published: (2018)

EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma
by: Lung, Raymond W.M., et al.
Published: (2018)

Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas
by: Jing Yongzheng, et al.
Published: (2010-11-01)

Diagnosis Of Nasopharyngeal Carcinoma By DNA Amplification Of EBV Genomes In Nasopharyngeal Biopsy And Fine Needle Aspiration Of Neck Nodes.
by: Hassan, Shahid, et al.
Published: (2004)

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.
by: Shanli Zhu, et al.
Published: (2020-01-01)

BZLF1 Expression of EBV is correlated with PARP1 Regulation on Nasopharyngeal Carcinoma Tissues
by: Wahyu nur laili fajri, Ahmad Rofi'i, Fatchiyah Fatchiyah
Published: (2013-04-01)

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
by: Lun-Quan Sun, et al.
Published: (2010-09-01)

TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma
by: Nabanita Roy Chattopadhyay, et al.
Published: (2020-03-01)

Detection of epstein - barr virus (EBV) in nasopharyngeal cancer.
by: Seow, Heng Fong
Published: (2007)

EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma
by: Cao-Li Tang, et al.
Published: (2024-01-01)

Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes
by: Y.L. Tang, et al.
Published: (2008-02-01)

A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
by: Jing Li, et al.
Published: (2014-01-01)

EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma
by: San Xu, et al.
Published: (2021-04-01)

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target
by: Oscar Emanuel, et al.
Published: (2021-09-01)

Retracted: A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy
by: Applied Bionics and Biomechanics
Published: (2023-01-01)

Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer
by: Hoi-Lam Ngan, et al.
Published: (2018-06-01)

Circulating EBV DNA and 18F-FDG PET scan in the diagnosis and monitoring of nasopharyngeal carcinoma
by: Wen-Yi Wang, et al.
Published: (2012-02-01)

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population
by: Ferrari Daris, et al.
Published: (2012-05-01)

Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma
by: Fenggang Yu, et al.
Published: (2021-04-01)

Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study.
by: Yim Ling Yip, et al.
Published: (2013-01-01)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
by: Ye Q, et al.
Published: (2021-07-01)